Article
Acquired mutations in transcriptional regulator hns and lipopolysaccharide biosynthesis and modification genes impact colistin resistance and fitness of mcr-carrying E. coli.
Antimicrobial agents and chemotherapy - 5 Aug 2026
Schumann Anna, O'Keefe Ian P, Ernst Robert K, Wiedmann Martin
Abstract excerpt
Gram-negative bacteria can develop resistance to the last-resort antimicrobial colistin through the acquisition of mobile colistin resistance (mcr) genes or chromosomal mutations. Bacteria carrying mcr variants do not always have colistin minimum inhibitory concentrations (MICs) above the clinical breakpoint, and there is a gap in understanding how mcr-carrying bacteria adapt to colistin selective pressure. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
